InsiderTrades

Form 4 for FENC FENNEC PHARMACEUTICALS INC.

Accepted 2024-04-16 00:00:00 ET · period of report 2024-04-15 · accession 0001415889-24-010901 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-04-16 2024-04-15+ FENC Haigh Adrian COO S - Sale $6.30 0 0 New $0
DM 2024-04-16 2024-04-15+ FENC Haigh Adrian COO M - OptEx $2.31 -44.4K 471.4K -9% -$102.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2024-04-15 S D 22,222 $10.30 22,222 D — — (F3) Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
2 Common Common Shares 2024-04-16 S A 22,222 $2.31 44,444 D — — (F2) Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
3 Common Common Shares 2024-04-15 S A 22,222 $2.31 22,222 D — — (F1) Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
4 Common Common Shares 2024-04-16 S D 22,222 $10.28 0 D — — (F4) Shares acquired pursuant to a 10b5-1 plan dated August 17, 2023.
5 Derivative Common Shares 2024-04-16 M D 22,222 $2.31 449,135 D $2.31 · 2014-04-25 to 2024-04-25 22,222 Options (F6) Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
6 Derivative Common Shares 2024-04-15 M D 22,222 $2.31 471,357 D $2.31 · 2014-04-25 to 2024-04-25 22,222 Options (F5) Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.